News Standard BioTools Inc.

Equities

LAB

US34385P1084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
2.61 ^USD	-3.69%		-8.10%	+18.10%

Apr. 16	TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target	MT
Apr. 08	Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target	Apr. 16	MT
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging	Apr. 08	AQ
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	Apr. 08	CI
Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target	Apr. 04	MT
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	Apr. 04	MT
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb	Apr. 04	MT
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research	Apr. 03	AQ
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock	Mar. 18	AQ
Transcript : Standard BioTools Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Standard BioTools: Q4 Earnings Snapshot	Feb. 28	AQ
Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024	Feb. 28	CI
Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Standard BioTools Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q4 Revenue $28.2M, vs. Street Est of $24.9M	Feb. 28	MT
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 28	AQ
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	Feb. 26	AQ
Standard BioTools Inc. and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	Feb. 26	CI
Standard BioTools to Participate in Upcoming Investor Conferences	Feb. 22	AQ
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	Feb. 14	AQ
Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine	Feb. 07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Standard BioTools Inc.

Equities

LAB

US34385P1084

Summary

Filters